SIK1
Serine/threonine-protein kinase SIK1
Also known as: msk, SIK1_HUMAN, SNF1LK
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P57059
- Gene
- SIK1
- Ensembl
- ENSG00000142178
- Chromosome
- 21
- Canonical length
- 783 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
This gene encodes a serine/threonine protein kinase that contains a ubiquitin-associated (UBA) domain. The encoded protein is a member of the adenosine monophosphate-activated kinase (AMPK) subfamily of kinases that play a role in conserved signal transduction pathways. A mutation in this gene is associated with early infantile epileptic encephalopathy 30. [provided by RefSeq, Nov 2016]
Canonical amino-acid sequenceUniProt
783 residues, UniProt reviewed canonical sequence.
>P57059|SIK1
1 MVIMSEFSAD PAGQGQGQQK PLRVGFYDIE RTLGKGNFAV VKLARHRVTK TQVAIKIIDK
61 TRLDSSNLEK IYREVQLMKL LNHPHIIKLY QVMETKDMLY IVTEFAKNGE MFDYLTSNGH
121 LSENEARKKF WQILSAVEYC HDHHIVHRDL KTENLLLDGN MDIKLADFGF GNFYKSGEPL
181 STWCGSPPYA APEVFEGKEY EGPQLDIWSL GVVLYVLVCG SLPFDGPNLP TLRQRVLEGR
241 FRIPFFMSQD CESLIRRMLV VDPARRITIA QIRQHRWMRA EPCLPGPACP AFSAHSYTSN
301 LGDYDEQALG IMQTLGVDRQ RTVESLQNSS YNHFAAIYYL LLERLKEYRN AQCARPGPAR
361 QPRPRSSDLS GLEVPQEGLS TDPFRPALLC PQPQTLVQSV LQAEMDCELQ SSLQWPLFFP
421 VDASCSGVFR PRPVSPSSLL DTAISEEARQ GPGLEEEQDT QESLPSSTGR RHTLAEVSTR
481 LSPLTAPCIV VSPSTTASPA EGTSSDSCLT FSASKSPAGL SGTPATQGLL GACSPVRLAS
541 PFLGSQSATP VLQAQGGLGG AVLLPVSFQE GRRASDTSLT QGLKAFRQQL RKTTRTKGFL
601 GLNKIKGLAR QVCQAPASRA SRGGLSPFHA PAQSPGLHGG AAGSREGWSL LEEVLEQQRL
661 LQLQHHPAAA PGCSQAPQPA PAPFVIAPCD GPGAAPLPST LLTSGLPLLP PPLLQTGASP
721 VASAAQLLDT HLHIGTGPTA LPAVPPPRLA RLAPGCEPLG LLQGDCEMED LMPCSLGTFV
781 LVQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SIK1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 82 nTPM
Expression across tissuesHPA
Tissue
- skin: 82 nTPM
- urinary bladder: 57 nTPM
- pancreas: 55 nTPM
- seminal vesicle: 52 nTPM
- adrenal gland: 51 nTPM
- bone marrow: 50 nTPM
Single-cell type
- suprabasal keratinocytes: 29 nCPM
- basal keratinocytes: 15 nCPM
- endometrial glandular cells: 10 nCPM
- papillary tip epithelial cells: 8.2 nCPM
- medullary thymic epithelial cells: 7.2 nCPM
- endometrial luminal cells: 5.9 nCPM
Immune cell
- plasmacytoid DC: 2 nTPM
- memory B-cell: 0.9 nTPM
- naive B-cell: 0.6 nTPM
- non-classical monocyte: 0.6 nTPM
- intermediate monocyte: 0.3 nTPM
- myeloid DC: 0.3 nTPM
Brain region
- cerebral cortex: 33 nTPM
- hypothalamus: 30 nTPM
- medulla oblongata: 29 nTPM
- pons: 22 nTPM
- midbrain: 22 nTPM
- thalamus: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SIK1.
Disease | AllUniProt
Conditions SIK1 is implicated in, by any mechanism.
- Developmental and epileptic encephalopathy 30 (DEE30) MIM:616341
Disease | GeneticClinVar
8 pathogenic / likely-pathogenic of 1,106 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Developmental and epileptic encephalopathy, 30
- Global developmental delay
- Language disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.34
- gnomAD pLI
- 0.94
- gnomAD missense Z
- 1.49
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anoikis
- cardiac muscle cell differentiation
- entrainment of circadian clock by photoperiod
- intracellular signal transduction
- negative regulation of CREB transcription factor activity
- negative regulation of gluconeogenesis
- negative regulation of transcription by RNA polymerase II
- negative regulation of triglyceride biosynthetic process
- positive regulation of anoikis
- protein autophosphorylation
- protein phosphorylation
- regulation of cell differentiation
- regulation of mitotic cell cycle
- regulation of myotube differentiation
- regulation of sodium ion transport
- rhythmic process
Molecular functions
- 14-3-3 protein binding
- ATP binding
- cAMP response element binding protein binding
- histone deacetylase binding
- magnesium ion binding
- protein kinase binding
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Ubiquitin-associated domain
- Serine/threonine-protein kinase, SIK1/2
- Protein kinase, ATP binding site
- Salt-Inducible kinase, catalytic domain
- Protein kinase SIK1/2/3, UBA domain
- Protein kinase domain
- Protein kinase SIK3 UBA domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SIK1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SIK1 as an antibody target. Whether an autoantibody or antibody against SIK1 could matter depends on whether native SIK1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SIK1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SIK1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...